Search research articles
Contact Us
Filters
Showing results (1261-1270 of 1,433) with videos related to
Page
of 144
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2019
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
V Guarneri, M V Dieci, G Bisagni, et al.
Explore (New York, N.Y.)
|
November 13, 2012
Patients seek integrative medicine for preventive approach to optimize health
Ruth Q Wolever, Donald I Abrams, Benjamin Kligler, et al.
Future Oncology (London, England)
|
May 14, 2021
Real-world data on treatment outcomes in <i>EGFR</i>-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines
Alessandro Dal Maso, Martina Lorenzi, Alessandra Ferro, et al.
The Journal of General Virology
|
November 13, 2025
From North to South: transmission dynamics of H1N1pdm09 swine influenza A viruses in Italy
Marta Giovanetti, Eleonora Cella, Laura Soliani, et al.
Contact Dermatitis
|
May 1, 2021
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018-2019
Luca Stingeni, Rossella Marietti, Leonardo Bianchi, et al.
The New Microbiologica
|
June 21, 2021
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era
Barbara Rossetti, Elisabetta Loggi, Chiara Spertilli Raffaelli, et al.
The British Journal of Dermatology
|
July 1, 2014
Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy
L Scalone, P A Cortesi, L G Mantovani, et al.
Therapeutic Advances in Medical Oncology
|
March 20, 2023
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
Giovanna Garufi, Luisa Carbognin, Isabella Sperduti, et al.
Cancer Treatment Reviews
|
August 28, 2023
Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread
Carmen Criscitiello, Chiara Corti, Michelino De Laurentiis, et al.
The Oncologist
|
April 16, 2022
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab
Giulia Pasello, Martina Lorenzi, Lorenzo Calvetti, et al.
Page
of 144
Search research articles
Search
Showing results (1261-1270 of 1,433) with videos related to
Sort By:
Page
of 144
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2019
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
V Guarneri, M V Dieci, G Bisagni, et al.
Explore (New York, N.Y.)
|
November 13, 2012
Patients seek integrative medicine for preventive approach to optimize health
Ruth Q Wolever, Donald I Abrams, Benjamin Kligler, et al.
Future Oncology (London, England)
|
May 14, 2021
Real-world data on treatment outcomes in <i>EGFR</i>-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines
Alessandro Dal Maso, Martina Lorenzi, Alessandra Ferro, et al.
The Journal of General Virology
|
November 13, 2025
From North to South: transmission dynamics of H1N1pdm09 swine influenza A viruses in Italy
Marta Giovanetti, Eleonora Cella, Laura Soliani, et al.
Contact Dermatitis
|
May 1, 2021
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018-2019
Luca Stingeni, Rossella Marietti, Leonardo Bianchi, et al.
The New Microbiologica
|
June 21, 2021
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era
Barbara Rossetti, Elisabetta Loggi, Chiara Spertilli Raffaelli, et al.
The British Journal of Dermatology
|
July 1, 2014
Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy
L Scalone, P A Cortesi, L G Mantovani, et al.
Therapeutic Advances in Medical Oncology
|
March 20, 2023
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
Giovanna Garufi, Luisa Carbognin, Isabella Sperduti, et al.
Cancer Treatment Reviews
|
August 28, 2023
Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread
Carmen Criscitiello, Chiara Corti, Michelino De Laurentiis, et al.
The Oncologist
|
April 16, 2022
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab
Giulia Pasello, Martina Lorenzi, Lorenzo Calvetti, et al.
Page
of 144